CorNeat Vision is a clinical-stage, biomimetic implants and technology company. Our patented material platform, the CorNeat EverMatrix™ seeks to displace the use of tissue (autografts, allografts, and xenografts) as well as degradable biological scaffolds used in a variety of surgical procedures across diversified fields of medicine. The EverMatrix™ provides the cornerstone for developing a wide array of implants that are safer, more reliable, long-lasting and easier to handle than available alternatives.